Chair(s)
Dr Virginia Olmos, Vice President FIP Bureau, Uruguay and Dr Lars-Åke Söderlund, Vice President FIP Bureau, SwedenIntroduction
This session on revolutionising health care with artificial intelligence (AI) will explore the impact of AI on pharmacy practices and health outcomes, addressing challenges and ethical considerations, and giving real-world examples. Insights into AI’s role in drug discovery, medication adherence and patient outcomes will cover crucial aspects like integration into pharmacy workflows, data security, education, training and regulatory considerations.
Programme
Confirmed speakers:
|
Learning objectives
Confirmed speakers:
|